Android app on Google Play

Viropharma, Inc. (VPHM) Misses Q1 EPS by 5c; Guides FY12 Revs Below Views

May 1, 2012 6:30 AM EDT Send to a Friend
Viropharma, Inc. (NASDAQ: VPHM) reported Q1 EPS of $0.37, $0.05 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $135.8 million versus the consensus estimate of $149.16 million.

Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.

For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment